Assessment of aprotinin influence on periodontal clinical status and matrix metalloproteinases 1, 2 and their tissue inhibitors saliva concentrations in patients with chronic periodontitis

Advances in Medical Sciences

Volumn 54, Issue 2, 2009, Pages 239-246

  Pietruska, M ^a   Pietruski, J ^b   Skurska, A ^a   Bernaczyk, A ^a   Zak, J ^a   Zelazowska, B ^a   Dolinska E ^a   Paniczko Drezek A ^a   Wysocka, J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Dental Practice   (Poland)

Author keywords

Aprotinin; Chronic periodontitis; Matrix metalloproteinases

Indexed keywords

APROTININ; GELATINASE A; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCODENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; MALE; PERIODONTITIS; PRESCRIPTION; SALIVA ANALYSIS;

ADULT; AGED; APROTININ; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DENTAL SCALING; FEMALE; GINGIVAL HEMORRHAGE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; ROOT PLANING; SALIVA; SERINE PROTEINASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 74949125629     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-009-0027-2     Document Type: Article

References (38)

1. Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Polson AM, Thomas J, Walker C. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J Clin Periodontol. 2001 Aug; 28(8):782-789
2. Layik M, Yamalik N, Caglayan F, Kilinc K, Etikan I, Eratalay K. Analysis of human gingival tissue and gingival crevicular fluid beta-glucuronidase activity in specific periodontal diseases. J Periodontol. 2000 Apr; 71(4):618-624
3. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol. 2002; 29 Suppl 3:136-59; discussion 160-162
4. Lamster IB, Kaufman E, Garbic JT, Winston LJ, Singer RE. Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol. 2003 Mar; 74(3):353-359
5. Kinane DF, Lappin DF. Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand. 2001 Jun;59(3):154-160
6. Dahan M, Nawrocki B, Elkaïm R, Soell M, Bolcato- Bellemin AL, Birembaut P, Tenenbaum H. Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol. 2001 Feb;28(2):128-136
7. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004 Nov;10(6):311-318
8. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, Konttinen YT, Sorsa T. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol. 1996 Dec;23(12):1127-1132
9. Korostoff JM, Wang JF, Sarment DP, Stewart JC, Feldman RS, Billings PC. Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol. 2000 Mar;71(3):353-360
10. Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, López-Otín C, Saarialho-Kere U, Kähäri VM. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol. 1998 Jun;152(6):1489-1499
11. Suomalainen K, Sorsa T, Saxén L, Vauhkonen M, Uitto VJ. Collagenase activity in gingival crevicular fluid of patients with juvenile periodontitis. Oral Microbiol Immunol. 1991 Feb;6(1):24-29
12. Tüter G, Kurtiş B, Serdar M. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. J Periodontol. 2002 May;73(5):487-493
13. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993 Feb;4(2):197-250.
14. Domeij H, Yucel-Lindberg T, Modéer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci. 2002 Aug;110(4):302-306
15. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res. 1994 Jul;8(2):312-319
16. Hanemaaijer R, Visser H, Koolwijk P, Sorsa T, Salo T, Golub LM, van Hinsbergh VW. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res. 1998 Nov;12(2):114-118
17. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res. 2003 Feb;82(2):82-90.
18. Lange DE, Plagmann HC, Eenboom A , Promesberger A. [Clinical methods for the objective evaluation of oral hygiene]. Dtsch Zahnarztl Z. 1977 Jan;32(1):44-47
19. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Inter Dent J. 1975 Dec;25(4):229-235
20. Ciancio SG. Systemic medications: clinical significance in periodontics. J Clin Periodontol. 2002 May;29 Suppl 2:17-21.
21. Norkiewicz DS, Breault LG, Wonderlich ST, Malone KH. The use of chemotherapeutic agents in localized periodontal pockets. Mil Med. 2001 Nov;166(11):940-946
22. Greenstein G, Polson A. The role of local drug delivery in the management of periodontal diseases: a comprehensive review. J Periodontol. 1998 May;69(5):507-520
23. Lewandowski B. Ocena przydatności preparatu Trascodent w praktyce chirurgiczno-stomatologicznej. Mag Stoma. 2007;2:2-3.
24. Westaby S. Aprotinin in perspective. Ann Thorac Surg. 1993 Apr;55(4):1033-1041
25. Majewska A, Nowak-Malinowska H. Traskolan w leczeniu zapaleń przyzȩbia. Czas Stomatol. 1985;38:515-520
26. Nowak-Malinowska H, Brzezińska B. Traskolan w leczeniu chorób tkanek okołoszczytowych zȩbów. Wrocławska stomatologia. 1986;14:205-210
27. Gilliland HE, Armstrong MA, Uprichard S, Clarke G, McMurray TJ. The effect of aprotinin on interleukin-8 concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system. Anaesthesia. 1999 May;54(5):427-433
28. Ashraf S, Tian Y, Cowan D, Nair U, Chatrath R, Saunders NR, Watterson KG, Martin PG. .,Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg. 1997 Jan;63(1):68-73.
29. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. J Clin Periodontol. 2001 Apr;28(4):353-359
30. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol. 1993 May;64(5 Suppl):474-484
31. Tüter G, Kurtiş B, Serdar M, Aykan T, Okyay K, Yücel A, Toyman U, Pinar S, Cemri M, Cengel A, Walker SG, Golub LM. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol. 2007 Aug;34(8):673-681
32. Knöfler GU, Purschwitz RE, Jentsch HF. Clinical evaluation of partial- and full-mouth scaling in the treatment of chronic periodontitis. J Periodontol. 2007 Nov;78(11):2135-2142
33. Tüter G, Kurtiş B, Serdar M. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. J Periodontol. 2002 May;73(5):487-493
34. Figueredo CM, Areas A, Miranda LA, Fischer RG, Gustafsson A. The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol. 2004 Aug;31(8):615-619
35. Wilton JM, Bampton JL, Griffiths GS, Curtis MA, Life JS, Johnson NW, Powell JR, Harrap GJ, Critchley P. Interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid from adults with previous evidence of destructive periodontitis. A cross sectional study. J Clin Periodontol. 1992 Jan;19(1):53-57
36. Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol. 1999 Dec;70(12):1457-1463
37. Palcanis KG, Larjava IK, Wells BR, Suggs KA, Landis JR, Chadwick DE, Jeffcoat MK. Elastase as an indicator of periodontal disease progression. J Periodontol. 1992 Apr;63(4):237-242
38. DeCarlo AA Jr, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiolproteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res. 1997 Jun;76(6):1260-1270